Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Mol Psychiatry ; 19(2): 175-83, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23337943

ABSTRACT

The G72/G30 gene complex is a candidate gene for schizophrenia and bipolar disorder. However, G72 and G30 mRNAs are expressed at very low levels in human brain, with only rare splicing forms observed. We report here G72/G30 expression profiles and behavioral changes in a G72/G30 transgenic mouse model. A human BAC clone containing the G72/G30 genomic region was used to establish the transgenic mouse model, on which gene expression studies, western blot and behavioral tests were performed. Relative to their minimal expression in humans, G72 and G30 mRNAs were highly expressed in the transgenic mice, and had a more complex splicing pattern. The highest G72 transcript levels were found in testis, followed by cerebral cortex, with very low or undetectable levels in other tissues. No LG72 (the long putative isoform of G72) protein was detected in the transgenic mice. Whole-genome expression profiling identified 361 genes differentially expressed in transgenic mice compared with wild-type, including genes previously implicated in neurological and psychological disorders. Relative to wild-type mice, the transgenic mice exhibited fewer stereotypic movements in the open field test, higher baseline startle responses in the course of the prepulse inhibition test, and lower hedonic responses in the sucrose preference test. The transcriptome profile changes and multiple mouse behavioral effects suggest that the G72 gene may play a role in modulating behaviors relevant to psychiatric disorders.


Subject(s)
Carrier Proteins/genetics , Carrier Proteins/metabolism , Motivation/physiology , Reflex, Startle/physiology , Stereotyped Behavior/physiology , Alternative Splicing , Animals , Brain/metabolism , COS Cells , Chlorocebus aethiops , Female , Food Preferences/physiology , Humans , Intracellular Signaling Peptides and Proteins , Male , Mental Disorders/genetics , Mice , Mice, Transgenic , Protein Isoforms/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Species Specificity , Testis/metabolism , Transcriptome
2.
Mol Psychiatry ; 19(10): 1106-14, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24166413

ABSTRACT

Current antidepressants must be administered for several weeks to produce therapeutic effects. We show that selective serotonin 2C (5-HT2C) antagonists exert antidepressant actions with a faster-onset (5 days) than that of current antidepressants (14 days) in mice. Subchronic (5 days) treatment with 5-HT2C antagonists induced antidepressant behavioral effects in the chronic forced swim test (cFST), chronic mild stress (CMS) paradigm and olfactory bulbectomy paradigm. This treatment regimen also induced classical markers of antidepressant action: activation of cAMP response element-binding protein (CREB) and induction of brain-derived neurotrophic factor (BDNF) in the medial prefrontal cortex (mPFC). None of these effects were induced by subchronic treatment with citalopram, a prototypical selective serotonin reuptake inhibitor (SSRI). Local infusion of 5-HT2C antagonists into the ventral tegmental area was sufficient to induce BDNF in the mPFC, and dopamine D1 receptor antagonist treatment blocked the antidepressant behavioral effects of 5-HT2C antagonists. 5-HT2C antagonists also activated mammalian target of rapamycin (mTOR) and eukaryotic elongation factor 2 (eEF2) in the mPFC, effects recently linked to rapid antidepressant action. Furthermore, 5-HT2C antagonists reversed CMS-induced atrophy of mPFC pyramidal neurons. Subchronic SSRI treatment, which does not induce antidepressant behavioral effects, also activated mTOR and eEF2 and reversed CMS-induced neuronal atrophy, indicating that these effects are not sufficient for antidepressant onset. Our findings reveal that 5-HT2C antagonists are putative fast-onset antidepressants, which act through enhancement of mesocortical dopaminergic signaling.


Subject(s)
Antidepressive Agents/pharmacology , Serotonin 5-HT2 Receptor Antagonists/pharmacology , Animals , Brain-Derived Neurotrophic Factor/metabolism , Chronic Disease , Citalopram/pharmacology , Cyclic AMP Response Element-Binding Protein/metabolism , Depressive Disorder/drug therapy , Depressive Disorder/pathology , Depressive Disorder/physiopathology , Disease Models, Animal , Elongation Factor 2 Kinase/metabolism , Female , Mice, Inbred BALB C , Olfactory Bulb/physiopathology , Prefrontal Cortex/drug effects , Prefrontal Cortex/pathology , Prefrontal Cortex/physiopathology , Pyramidal Cells/drug effects , Pyramidal Cells/pathology , Pyramidal Cells/physiopathology , Receptor, Serotonin, 5-HT2C/metabolism , Receptors, Dopamine D1/antagonists & inhibitors , Receptors, Dopamine D1/metabolism , Selective Serotonin Reuptake Inhibitors/pharmacology , Stress, Psychological , TOR Serine-Threonine Kinases/metabolism , Time Factors
3.
Mol Psychiatry ; 18(12): 1273-80, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23044705

ABSTRACT

Early life exposure to specific environmental factors can increase risk for developing psychopathology including major depression in adulthood. However, the molecular pathways and epigenetic mechanisms that mediate the effects of early environments on adult mood remain poorly understood. We examined the effects of different gestational and rearing conditions on adult anxiety- and depression-like behavior using a combined reciprocal outcrossing and cross-fostering design in Balb/cJ (cJ) and C57BL/6J (B6) mouse strains. First filial (F1) hybrid offspring, which were gestated by B6 or cJ dams and then reared by either strain, were evaluated for behavior and whole-genome hippocampal gene expression during adulthood. Adult hybrid mice gestated by B6 dams showed increased depression-like behavior in the forced swim and sucrose preference tests, increased hippocampal expression of alpha calcitonin gene-related peptide (αCGRP) transcripts, and decreased methylation of the αCGRP promoter compared with those gestated by cJ dams. Differential expression of αCGRP in adulthood did not result from genomic imprinting, and differences between B6 and cJ mitochondrial DNA were not responsible for behavioral phenotypes observed. Finally, central administration of αCGRP to adult hybrid mice increased depression-like behavior, whereas the CGRP1 receptor antagonist CGRP8-37 reduced depression-like behavior in the forced swim test. Our findings suggest that gestational factors influence adult depression-like behavior through methylation of the αCGRP gene.


Subject(s)
Animals, Newborn/psychology , Calcitonin Gene-Related Peptide/genetics , Depression/genetics , Prenatal Exposure Delayed Effects/psychology , Animals , Animals, Newborn/genetics , DNA Methylation , Depression/etiology , Environment , Female , Gene Expression Profiling , Hippocampus/metabolism , Hippocampus/physiology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Oligonucleotide Array Sequence Analysis , Pregnancy , Prenatal Exposure Delayed Effects/genetics , Real-Time Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL